Central Nervous System Metabolism in Autism, Epilepsy and Developmental Delays: A Cerebrospinal Fluid Analysis

• Main Authors: Adelson, P.D (Author), Arango, J.I (Author), Brister, D. (Author), Brown, D. (Author), Burrows, B.T (Author), Carpentieri, D. (Author), Flood, M. (Author), Flores, A. (Author), Frye, R.E (Author), Gideon, G. (Author), Gu, H. (Author), Jin, Y. (Author), Lane, A. (Author), Ly, N.H (Author), Marsh, W. (Author), McCarty, P.J (Author), McLees, S. (Author), Pankratz, M.T (Author), Werner, B.A (Author)
• Format: Article
• Language: English
• Published: MDPI 2022
• Subjects: amino acid metabolism; autism spectrum disorder; cerebrospinal fluid; cis-cis-muconic acid; developmental delay; energy metabolism; epilepsy; mass spectrometry; metabolomics; redox metabolism; shikimic acid; vitamins
• Online Access: View Fulltext in Publisher

 Neurodevelopmental disorders are associated with metabolic pathway imbalances; how-ever, most metabolic measurements are made peripherally, leaving central metabolic disturbances under-investigated. Cerebrospinal fluid obtained intraoperatively from children with autism spectrum disorder (ASD, n = 34), developmental delays (DD, n = 20), and those without known DD/ASD (n = 34) was analyzed using large-scale targeted mass spectrometry. Eighteen also had epilepsy (EPI). Metabolites significantly related to ASD, DD and EPI were identified by linear models and entered into metabolite–metabolite network pathway analysis. Common disrupted pathways were analyzed for each group of interest. Central metabolites most involved in metabolic pathways were L-cysteine, adenine, and dodecanoic acid for ASD; nicotinamide adenine dinucleotide phosphate, L-aspartic acid, and glycine for EPI; and adenosine triphosphate, L-glutamine, ornithine, L-arginine, L-lysine, citrulline, and L-homoserine for DD. Amino acid and energy metabolism pathways were most disrupted in all disorders, but the source of the disruption was different for each disorder. Disruption in vitamin and one-carbon metabolism was associated with DD and EPI, lipid pathway disruption was associated with EPI and redox metabolism disruption was related to ASD. Two microbiome metabolites were also detected in the CSF: shikimic and cis-cis-muconic acid. Overall, this study provides increased insight into unique metabolic disruptions in distinct but overlapping neurodevelopmental disorders. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.